About 9 results found for searched term "MAGL" (0.128 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M10035 | Semaglutide | GLP Receptor |
| Rybelsus; Ozempic; NN9535; OG217SC; NNC 0113-0217 | ||
| Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217) is a long-acting human GLP-1 analog, it is also a GLP-1 receptor agonist with the potential for the treatment of type 2 diabetes mellitus (T2DM). | ||
| M13972 | Semaglutide TFA | GLP Receptor |
| Semaglutide TFA, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide TFA has the potential for type 2 diabetes treatment. | ||
| M21099 | MAGLi 432 | MAGL |
| MAGLi 432 is a novel, reversible inhibitor of monoacylglycerol lipase (MAGL). | ||
| M29617 | MAGL-IN-6 | MAGL |
| MAGL-IN-6 is a potent MAGL inhibitor with an IC50 of 4.71 nM. MAGL-IN-6 can be used for neurological disorders research (WO2020065613A1; example 234). | ||
| M29986 | MAGL-IN-5 | MAGL |
| CAY10499 | ||
| MAGL-IN-5 (CAY10499) is a non-selective lipase inhibitor with IC50 values of 144, 90, and 14 nM for human recombinant monoacylglycerol lipase(MAGL),hormone sensitive lipase(HSL), and fatty acid amide hydrolase(FAAH) respectively. | ||
| M30403 | Pomaglumetad methionil hydrochloride | GluR |
| LY2140023 hydrochloride | ||
| Pomaglumetad methionil hydrochloride (LY2140023 hydrochloride) is an orally active, methionine precursor of the selective mGlu2/3 receptor agonist LY404039. Pomaglumetad methionil hydrochloride has the potential for schizophrenia research. | ||
| M30404 | Pomaglumetad methionil anhydrous | GluR |
| LY2140023 | ||
| Pomaglumetad methionil anhydrous (LY2140023) is an orally active, methionine precursor of the selective mGlu2/3 receptor agonist LY404039. LY2140023 has the potential for schizophrenia research. | ||
| M30972 | Pomaglumetad methionil | GluR |
| LY2140023 hydrate | ||
| Pomaglumetad methionil (LY2140023 hydrate) is an oral methionine precursor of the potent specific mGlu2/3 receptor agonist LY404039. Pomaglumetad methionil is well-tolerated and has a distinct safety profile, and can be used for schizophrenia. | ||
| M42982 | Vamagloxistat | Others |
| Vamagloxistat is glycolate oxidase inhibitor, used to inhibit hyperoxaluria and kidney stones. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
